Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers
2007 · JNCI Journal of the National Cancer Institute · 250 citations
https://doi.org/10.1093/jnci/djm198
S
Shanthi Ganesh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
3.2K
Citations
25
h-index
34
i10-index
Shanthi Ganesh is an academic researcher from Novo Nordisk (Denmark). The author has contributed to research in topics: RNA Interference and Gene Delivery & Virus-based gene therapy research & RNA modifications and cancer. The author has an h-index of 25, co-authored 76 publications.
ORCID: 0000-0001-9278-0865Papers by this author
worksCombination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
2013 · Molecular Therapy — Nucleic Acids · 133 citations
https://doi.org/10.1038/mtna.2013.29
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
2024 · Molecular Therapy · 21 citations
https://doi.org/10.1016/j.ymthe.2024.03.035
Arthritis Activity and Work Limitation in Behavioral Risk Factor Surveillance System 2011-2013 Data
2016 · Figshare · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat